Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gert Luurtsema

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Molecules (Basel, Switzerland)|September 27, 2025
Designing a Small Molecule for PET Radiotracing: [<sup>18</sup>F]MC225 in Human Trials for Early Diagnosis in CNS PathologiesFrancesco Mastropasqua, Gert Luurtsema, Cristina Filosa, et al.
EJNMMI Research|July 24, 2020
Automated synthesis, preclinical toxicity, and radiation dosimetry of [<sup>18</sup>F]MC225 for clinical use: a tracer for measuring P-glycoprotein function at the blood-brain barrierJun Toyohara, Muneyuki Sakata, Tetsuro Tago, et al.
Current Pharmaceutical Design|August 30, 2016
PET Tracers for Imaging of ABC Transporters at the Blood-Brain Barrier: Principles and StrategiesGert Luurtsema, Philip Elsinga, Rudi Dierckx, et al.
Organic Letters|May 16, 2019
Synthesis of Substituted Benzaldehydes via a Two-Step, One-Pot Reduction/Cross-Coupling ProcedureDorus Heijnen, Hugo Helbert, Gert Luurtsema, et al.
Journal of Parkinson'S Disease|August 29, 2013
New perspectives in nuclear neurology for the evaluation of Parkinson's diseaseMarcel Benadiba, Gert Luurtsema, Vitor Tumas, et al.
Expert Opinion on Therapeutic Patents|May 14, 2019
An updated patent review on P-glycoprotein inhibitors (2011-2018)Marcello Leopoldo, Patrizia Nardulli, Marialessandra Contino, et al.
Current Opinion in Drug Discovery & Development|August 30, 2008
Positron emission tomography for modeling pathophysiological processes in vivoN Harry Hendrikse, Gert Luurtsema, Astrid A M van der Veldt, et al.
Pharmaceuticals (Basel, Switzerland)|December 23, 2023
Cardiac PET Imaging of ATP Binding Cassette (ABC) Transporters: Opportunities and ChallengesWanling Liu, Pascalle Mossel, Verena Schwach, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|February 23, 2013
New molecular targets for PET and SPECT imaging in neurodegenerative diseasesMarcel Benadiba, Gert Luurtsema, Lauro Wichert-Ana, et al.
EJNMMI Radiopharmacy and Chemistry|October 10, 2021
EANM guideline for harmonisation on molar activity or specific activity of radiopharmaceuticals: impact on safety and imaging qualityGert Luurtsema, Verena Pichler, Salvatore Bongarzone, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Molecules (Basel, Switzerland)|September 27, 2025
Designing a Small Molecule for PET Radiotracing: [<sup>18</sup>F]MC225 in Human Trials for Early Diagnosis in CNS PathologiesFrancesco Mastropasqua, Gert Luurtsema, Cristina Filosa, et al.
EJNMMI Research|July 24, 2020
Automated synthesis, preclinical toxicity, and radiation dosimetry of [<sup>18</sup>F]MC225 for clinical use: a tracer for measuring P-glycoprotein function at the blood-brain barrierJun Toyohara, Muneyuki Sakata, Tetsuro Tago, et al.
Current Pharmaceutical Design|August 30, 2016
PET Tracers for Imaging of ABC Transporters at the Blood-Brain Barrier: Principles and StrategiesGert Luurtsema, Philip Elsinga, Rudi Dierckx, et al.
Organic Letters|May 16, 2019
Synthesis of Substituted Benzaldehydes via a Two-Step, One-Pot Reduction/Cross-Coupling ProcedureDorus Heijnen, Hugo Helbert, Gert Luurtsema, et al.
Journal of Parkinson'S Disease|August 29, 2013
New perspectives in nuclear neurology for the evaluation of Parkinson's diseaseMarcel Benadiba, Gert Luurtsema, Vitor Tumas, et al.
Expert Opinion on Therapeutic Patents|May 14, 2019
An updated patent review on P-glycoprotein inhibitors (2011-2018)Marcello Leopoldo, Patrizia Nardulli, Marialessandra Contino, et al.
Current Opinion in Drug Discovery & Development|August 30, 2008
Positron emission tomography for modeling pathophysiological processes in vivoN Harry Hendrikse, Gert Luurtsema, Astrid A M van der Veldt, et al.
Pharmaceuticals (Basel, Switzerland)|December 23, 2023
Cardiac PET Imaging of ATP Binding Cassette (ABC) Transporters: Opportunities and ChallengesWanling Liu, Pascalle Mossel, Verena Schwach, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)|February 23, 2013
New molecular targets for PET and SPECT imaging in neurodegenerative diseasesMarcel Benadiba, Gert Luurtsema, Lauro Wichert-Ana, et al.
EJNMMI Radiopharmacy and Chemistry|October 10, 2021
EANM guideline for harmonisation on molar activity or specific activity of radiopharmaceuticals: impact on safety and imaging qualityGert Luurtsema, Verena Pichler, Salvatore Bongarzone, et al.
Pageof 10